Mark Butler's decision to 'respectfully' write to the PBAC to ask that it reconsider its previous advice on the GSK therapies was an unnecessary but subtle and entirely legitimate exercise of this ministerial power over PBS decision-making.
The minister did not need the committee's advice to reverse these changes
May 15, 2023 Latest NewsBioPharmaComment
Latest Video
New Stories
-
Moderna announces positive Phase 3 result for influenza vaccine
July 1, 2025 - - Latest News -
Research lagging for sarcoma, despite accounting for one third of adolescent cancer deaths
July 1, 2025 - - Latest News -
Takeda therapy now available through the PBS for serious viral infection
July 1, 2025 - - Latest News -
The real question is why expectations were so high in the first place
July 1, 2025 - - Latest News -
National Pharmacies appoints experienced industry leader as new CEO
July 1, 2025 - - Latest News -
Tetratherix lists on the ASX following successful IPO
June 30, 2025 - - Australian Biotech -
LTR Pharma achieves key FDA milestone through extractables study
June 30, 2025 - - Australian Biotech